Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
33.98
-1.12 (-3.19%)
At close: Apr 28, 2026, 4:00 PM EDT
34.00
+0.02 (0.06%)
After-hours: Apr 28, 2026, 7:52 PM EDT

Capricor Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
231
Market Cap
1.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Aurinia Pharmaceuticals 283.06M
AnaptysBio 234.60M
Stoke Therapeutics 184.42M
Syndax Pharmaceuticals 172.35M
Zymeworks 105.97M
Mesoblast 65.38M
Ocular Therapeutix 51.95M
Revenue Rankings

CAPR News

More News